CSL Behring UK Ltd supports Rare Disease UK

UK Patient group campaigns for strategic planning for rare diseases

UK — 31.03.2010

CSL Behring UK Ltd announced today that it had joined the patient group Rare Disease UK as an industry member. The patient group campaigns for strategic planning for rare diseases in the UK in response to unmet health care needs of hundreds of thousands of families who currently struggle to get access to integrated care and support from the NHS.

CSL Behring has a natural affinity with the patient group due to its current product portfolio which treats and manages a range of rare diseases including haemophilia and other coagulation disorders, immune deficiencies as well as helping to prevent haemolytic disease of the newborn.

By joining Rare Disease UK as an industry member, CSL Behring hopes to add its weight to the campaign for better planning and management for rare diseases and greater support for those patients affected by these conditions.

For further information on Rare Disease UK, please visit their website at www.raredisease.org.uk

About CSL Behring
CSL Behring is a global leader in the plasma protein biotherapeutics industry. Passionate about improving the quality of patients’ lives, CSL Behring manufactures and markets a range of effective plasma-derived and recombinant products and related services. The company’s therapies are used in the treatment of rare diseases such as immune deficiency disorders, haemophilia, von Willebrand disease and other bleeding disorders. Other products are used for the prevention of haemolytic diseases in the newborn. The company also operates one of the world’s largest plasma collection networks, CSL Plasma. CSL Behring is a subsidiary of CSL Limited, a biopharmaceutical company with headquarters in Melbourne, Australia. For more information, visit www.cslbehring.co.uk

About Rare Disease UK

Rare Disease UK is a joint initiative of the Genetic Interest Group, (the UK alliance of patient organisations with a membership of over 130 charities which support children, families and individuals affected by genetic disorders) and others in response to unmet health care needs of families who currently struggle to get access to integrated care and support from the NHS. For further information, visit www.raredisease.org.uk

Further Information:

Medical Information on 01444 447 405 / CSL Behring Medical Information

Customer Services on 01444 447 402 / CSL Behring UK Customer Service